10 research outputs found
The Effect of Dietary Supplementation with Spent Cider Yeast on the Swine Distal Gut Microbiome
peer-reviewedBackground: There is an increasing need for alternatives to antibiotics for promoting animal health, given the increasing
problems associated with antibiotic resistance. In this regard, we evaluated spent cider yeast as a potential probiotic for
modifying the gut microbiota in weanling pigs using pyrosequencing of 16S rRNA gene libraries.
Methodology and Principal Findings: Piglets aged 24–26 days were assigned to one of two study groups; control (n = 12)
and treatment (n = 12). The control animals were fed with a basal diet and the treatment animals were fed with basal diet in
combination with cider yeast supplement (500 ml cider yeast containing ,7.6 log CFU/ml) for 21 days. Faecal samples were
collected for 16s rRNA gene compositional analysis. 16S rRNA compositional sequencing analysis of the faecal samples
collected from day 0 and day 21 revealed marked differences in microbial diversity at both the phylum and genus levels
between the control and treatment groups. This analysis confirmed that levels of Salmonella and Escherichia were
significantly decreased in the treatment group, compared with the control (P,0.001). This data suggest a positive influence
of dietary supplementation with live cider yeast on the microbial diversity of the pig distal gut.
Conclusions/Significance: The effect of dietary cider yeast on porcine gut microbial communities was characterized for the
first time using 16S rRNA gene compositional sequencing. Dietary cider yeast can potentially alter the gut microbiota,
however such changes depend on their endogenous microbiota that causes a divergence in relative response to that given
diet.This work was funded by Enterprise Ireland, under the Commercialisation Fund (Contract No: CFTD/05/117), the Irish Government under the National
Development Plan, 2000–2006, the European Research and Development Fund and Science Foundation Ireland (SFI).European Research and Development Fun
Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases
peer-reviewedBacteriophages (phages) or bacterial viruses have been proposed as natural antimicrobial
agents to fight against antibiotic-resistant bacteria associated with human infections. Enterococcus faecalis
is a gut commensal, which is occasionally found in the mouth and vaginal tract, and does not
usually cause clinical problems. However, it can spread to other areas of the body and cause
life-threatening infections, such as septicemia, endocarditis, or meningitis, in immunocompromised
hosts. Although E. faecalis phage cocktails are not commercially available within the EU or USA,
there is an accumulated evidence from in vitro and in vivo studies that have shown phage efficacy,
which supports the idea of applying phage therapy to overcome infections associated with E. faecalis.
In this review, we discuss the potency of bacteriophages in controlling E. faecalis, in both in vitro and
in vivo scenarios. E. faecalis associated bacteriophages were compared at the genome level and an
attempt was made to categorize phages with respect to their suitability for therapeutic application,
using orthocluster analysis. In addition, E. faecalis phages have been examined for the presence
of antibiotic-resistant genes, to ensure their safe use in clinical conditions. Finally, the domain
architecture of E. faecalis phage-encoded endolysins are discussed
Evaluation of Phage Therapy in the Context of Enterococcus faecalis and Its Associated Diseases
Bacteriophages (phages) or bacterial viruses have been proposed as natural antimicrobial
agents to fight against antibiotic-resistant bacteria associated with human infections. Enterococcus faecalis
is a gut commensal, which is occasionally found in the mouth and vaginal tract, and does not
usually cause clinical problems. However, it can spread to other areas of the body and cause
life-threatening infections, such as septicemia, endocarditis, or meningitis, in immunocompromised
hosts. Although E. faecalis phage cocktails are not commercially available within the EU or USA,
there is an accumulated evidence from in vitro and in vivo studies that have shown phage efficacy,
which supports the idea of applying phage therapy to overcome infections associated with E. faecalis.
In this review, we discuss the potency of bacteriophages in controlling E. faecalis, in both in vitro and
in vivo scenarios. E. faecalis associated bacteriophages were compared at the genome level and an
attempt was made to categorize phages with respect to their suitability for therapeutic application,
using orthocluster analysis. In addition, E. faecalis phages have been examined for the presence
of antibiotic-resistant genes, to ensure their safe use in clinical conditions. Finally, the domain
architecture of E. faecalis phage-encoded endolysins are discussed
Unweighted principal component analysis.
<p>For: a) control and treatment animals in day 0 (blue), control animals in day 21 (green) and treatment animals in day 21 (red) b) control animals in day 0 (blue) and control animals in day 21 (red) c) treatment animals in day 0 (blue) and treatment animals in day 21(red) d) control animals in day 21 (blue) and treatment animals in day 21 (red). UPGMA clustering and Jackkniffing for the unweighted UniFrac data e) For the UPGMA cladogram on the left: Orange colour represents animals in day 0; red for the control animals in day 21 and blue for the treatment animals in day21. d) For the Jackknife supported tree layout the labels are coloured according to the group as: Black for animals in day 0; red for the control animals in day 21 and blue for treatment animals in day 21. The lines are coloured by the Jackknife supported percentages: Red for 75–100% support; Green for 50–75% support; Yellow for 25–50% support and Blue for <25% support.</p
Percentage relative abundance of OTUs observed at the phylum, class, order and family levels in the pig distal gut microbiota at day 0, day 21 C (control) and day 21 T (treatment-cider yeast supplemented) groups.
<p>Percentage relative abundance of OTUs observed at the phylum, class, order and family levels in the pig distal gut microbiota at day 0, day 21 C (control) and day 21 T (treatment-cider yeast supplemented) groups.</p
Percentage of relative abundance change at genus level in the control and treatment animals at day 21 (P<0.001).
<p>Percentage of relative abundance change at genus level in the control and treatment animals at day 21 (P<0.001).</p
Viral biogeography of the mammalian gut and parenchymal organs
The mammalian virome has been linked to health and disease but our understanding of how it is structured along the longitudinal axis of the mammalian gastrointestinal tract (GIT) and other organs is limited. Here, we report a metagenomic analysis of the prokaryotic and eukaryotic virome occupying luminal and mucosa-associated habitats along the GIT, as well as parenchymal organs (liver, lung and spleen), in two representative mammalian species, the domestic pig and rhesus macaque (six animals per species). Luminal samples from the large intestine of both mammals harboured the highest loads and diversity of bacteriophages (class Caudoviricetes, family Microviridae and others). Mucosal samples contained much lower viral loads but a higher proportion of eukaryotic viruses (families Astroviridae, Caliciviridae, Parvoviridae). Parenchymal organs contained bacteriophages of gut origin, in addition to some eukaryotic viruses. Overall, GIT virome composition was specific to anatomical region and host species. Upper GIT and mucosa-specific viruses were greatly under-represented in distal colon samples (a proxy for faeces). Nonetheless, certain viral and phage species were ubiquitous in all samples from the oral cavity to the distal colon. The dataset and its accompanying methodology may provide an important resource for future work investigating the biogeography of the mammalian gut virome
Viral biogeography of the mammalian gut and parenchymal organs
The mammalian virome has been linked to health and disease but our understanding of how it is structured along the longitudinal axis of the mammalian gastrointestinal tract (GIT) and other organs is limited. Here, we report a metagenomic analysis of the prokaryotic and eukaryotic virome occupying luminal and mucosa-associated habitats along the GIT, as well as parenchymal organs (liver, lung and spleen), in two representative mammalian species, the domestic pig and rhesus macaque (six animals per species). Luminal samples from the large intestine of both mammals harboured the highest loads and diversity of bacteriophages (class Caudoviricetes, family Microviridae and others). Mucosal samples contained much lower viral loads but a higher proportion of eukaryotic viruses (families Astroviridae, Caliciviridae, Parvoviridae). Parenchymal organs contained bacteriophages of gut origin, in addition to some eukaryotic viruses. Overall, GIT virome composition was specific to anatomical region and host species. Upper GIT and mucosa-specific viruses were greatly under-represented in distal colon samples (a proxy for faeces). Nonetheless, certain viral and phage species were ubiquitous in all samples from the oral cavity to the distal colon. The dataset and its accompanying methodology may provide an important resource for future work investigating the biogeography of the mammalian gut virome